CRIS Current Research Information System

FONTANA, MARIA CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.600
NA - Nord America 3.473
EU - Europa 2.550
AF - Africa 277
SA - Sud America 136
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
Totale 10.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.421
VN - Vietnam 1.311
SG - Singapore 862
CN - Cina 745
GB - Regno Unito 653
IT - Italia 392
SE - Svezia 341
DE - Germania 317
HK - Hong Kong 189
FR - Francia 166
IN - India 136
NL - Olanda 122
RU - Federazione Russa 117
IE - Irlanda 106
BR - Brasile 105
FI - Finlandia 77
TG - Togo 75
JP - Giappone 66
ZA - Sudafrica 59
CI - Costa d'Avorio 52
NG - Nigeria 50
EE - Estonia 44
KR - Corea 41
UA - Ucraina 38
BE - Belgio 34
BG - Bulgaria 33
JO - Giordania 33
CA - Canada 31
PH - Filippine 29
CH - Svizzera 27
ID - Indonesia 24
TH - Thailandia 24
SC - Seychelles 22
IQ - Iraq 19
BD - Bangladesh 18
AR - Argentina 16
PL - Polonia 16
UZ - Uzbekistan 15
TW - Taiwan 14
ES - Italia 13
GR - Grecia 13
IR - Iran 13
AT - Austria 12
TR - Turchia 12
MX - Messico 11
PK - Pakistan 9
EU - Europa 8
AU - Australia 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
MK - Macedonia 6
MY - Malesia 5
EC - Ecuador 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
LT - Lituania 4
PY - Paraguay 4
CL - Cile 3
DZ - Algeria 3
JM - Giamaica 3
LB - Libano 3
MA - Marocco 3
NP - Nepal 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
CO - Colombia 2
CY - Cipro 2
KH - Cambogia 2
LV - Lettonia 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BW - Botswana 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 10.052
Salva come PNG Salva come JPEG
Città #
Singapore 623
Southend 586
Dong Ket 521
Ashburn 414
Chandler 345
Fairfield 252
Ann Arbor 203
Hong Kong 177
Ho Chi Minh City 175
Hanoi 168
Houston 150
San Jose 146
Beijing 145
Wilmington 138
Seattle 132
Woodbridge 124
Cambridge 116
Dublin 105
Princeton 98
Santa Clara 91
Boardman 87
Bologna 80
Lomé 75
New York 60
Tokyo 58
Abidjan 52
Nanjing 47
Helsinki 46
Lauterbourg 46
Los Angeles 46
Westminster 45
Hefei 42
Padova 42
Medford 41
Munich 36
Abeokuta 34
Brussels 33
Sofia 33
Amman 32
Haiphong 30
Frankfurt am Main 28
Seoul 26
Bremen 24
Buffalo 24
Dallas 24
Berlin 23
Da Nang 23
Milan 23
Redondo Beach 23
Guangzhou 22
Saint Petersburg 22
Redwood City 21
Redmond 20
Shanghai 19
Turin 19
Bern 18
Hebei 17
Jinan 17
San Diego 17
Toronto 17
Florence 16
Lappeenranta 16
London 16
Nanchang 16
Shenyang 16
Changsha 15
Jakarta 14
Jiaxing 14
Turku 14
Biên Hòa 12
Council Bluffs 12
Hải Dương 12
Paris 12
São Paulo 12
Tianjin 12
Chengdu 11
Johannesburg 11
Nuremberg 11
Orem 11
Zhengzhou 11
Chennai 10
Mountain View 10
Warsaw 10
Falkenstein 9
Norwalk 9
Vienna 9
Atlanta 8
Baghdad 8
Düsseldorf 8
Hangzhou 8
Phoenix 8
Taizhou 8
Amsterdam 7
Athens 7
Bangkok 7
Brooklyn 7
Busseto 7
Can Tho 7
Falls Church 7
Hyderabad 7
Totale 6.526
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 381
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 291
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 289
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 281
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 253
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 251
Co-occurrence of alterations in the DNA damage repair genes synergize with uncontrolled proliferation and associate with very-poor prognosis in acute myeloid leukemia patients 249
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 248
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 246
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 232
Chromothripsis in Acute Myeloid Leukemia Is Strongly Associated with Poor Prognosis and TP53 Alterations 230
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia 229
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 228
Chromothripsis in AML patients: A new mechanism of cancer initiation and progression 227
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 223
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis 211
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 208
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 202
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 200
Novel Genomic Patterns of Metabolic Remodeling in Acute Myeloid Leukemia 196
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 190
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 189
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 188
A new biomarker of response to 5-azacitidine therapy in MDS and AML patients: SIRPB1 188
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 187
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 186
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 185
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 182
Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations 181
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 173
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 172
The Genomic and Transcriptomic Landscape of Systemic Mastocytosis 171
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 170
Survival and outcome data observed in 98 patients affected by acute myeloid leukemia undergoing chemotherapy consolidation courses treatment followed by autologous bone marrow transplantation (auto-BMT) 169
Effect of production process and high-pressure processing on viability of Listeria innocua in traditional Italian dry-cured coppa 168
SNP array reveals a new deletion of JAK2 in AML patients 162
A Three-Genes Signature of Anti-Apoptotic Genes Showed Different Mechanisms in Preventing Apoptosis in Acute Myeloid Leukemia Cells and Could Provide an Useful Model to Establish the Proper BH3-Mimetich Drug or Combination 161
Genomic wide microarray analysis identifies novel copy number alterations in adult acute myeloid leukemia 156
Survival analysis of 409 consecutive patients with newly diagnosed acute myeloid leukemia treated with intensive induction therapy, with or without the addition of gemtuzomab-ozagomicin (GO) 154
Genome-Wide Molecular Portrait of Aggressive Systemic Mastocytosis and Mast Cell Leukemia Depicted By Whole Exome Sequencing and Copy Number Variation Analysis 153
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 153
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 152
SETD2 Non-Genomic Loss of Function and p53 Functional Inactivation in Advanced Systemic Mastocytosis (SM): Pathogenetic and Therapeutic Implications 151
Specific chromosomic alterations confer therapy resistance in a cohort of 49 patients with newly diagnosed acute myeloid leukemia treated with intensive chemotherapy 150
Genomic-Wide Analysis By High Resolution SNP Array Identifies Novel Genomic Alteration in Acute Myeloid Leukemia 149
Single nucleotide polymorphisms as genomic markers for high-throughput pharmacogenomic studies 147
Effect of production process and high-pressure processing on viability of Salmonella spp. in traditional Italian dry-cured coppa 139
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x) 134
Pharmacological interaction and side effects in oncohaematology: a retrospective observational study 128
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 121
New JAK2 heterozygous loss: A role in overall survival in acute myeloid leukemia patients 120
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a 100
EFFETTO DELL’AZIONE DEI RAGGI INFRAROSSI SULLA CARICA BATTERICA PATOGENA DI LATTE CRUDO VACCINO 73
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia 69
PREVALENCE OF SALMONELLA ENTERICA SUBSP. ENTERICA IN HEDGEHOG (ERINACEUS EUROPAEUS) IN FERRARA PROVINCE (EMILIA ROMAGNA, ITALY) 65
Acute myeloid leukemia mutations: Therapeutic implications 51
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia 6
Totale 10.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.497
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.497
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021775 0 0 0 0 0 0 0 0 0 42 71 662
2021/20221.115 106 33 53 117 114 56 31 63 57 71 228 186
2022/20231.380 155 202 73 185 105 104 36 67 251 30 119 53
2023/2024394 15 49 17 47 24 101 30 27 21 30 21 12
2024/20251.376 36 217 139 100 110 38 178 62 14 162 74 246
2025/20263.009 311 189 215 212 340 153 270 88 954 277 0 0
Totale 10.268